Loading...
ProPhase Labs, Inc.
PRPH•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.47
$0.04(10.56%)
ProPhase Labs, Inc. (PRPH) Financial Performance & Income Statement Overview
Review ProPhase Labs, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-84.75%
↓ 84.75%
Operating Income Growth
-78.73%
↓ 78.73%
Net Income Growth
-217.98%
↓ 217.98%
Operating Cash Flow Growth
-54.55%
↓ 54.55%
Operating Margin
-744.34%
↓ 744.34%
Gross Margin
17.71%
↑ 17.71%
Net Profit Margin
-944.45%
↓ 944.45%
ROE
-164.83%
↓ 164.83%
ROIC
-130.45%
↓ 130.45%
ProPhase Labs, Inc. (PRPH) Income Statement & Financial Overview
Review ProPhase Labs, Inc.'s (PRPH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | -$2.48M | $3.15M | $2.47M | $3.63M |
| Cost of Revenue | -$3.41M | $3.31M | $2.95M | $4.07M |
| Gross Profit | $924000.00 | -$165000.00 | -$476000.00 | -$433000.00 |
| Gross Profit Ratio | -$0.37 | -$0.05 | -$0.19 | -$0.12 |
| R&D Expenses | $61000.00 | $122000.00 | $139000.00 | $272000.00 |
| SG&A Expenses | $15.43M | $7.65M | $7.21M | $7.59M |
| Operating Expenses | $15.49M | $7.77M | $7.35M | $7.87M |
| Total Costs & Expenses | $12.08M | $11.08M | $10.30M | $11.93M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.03M | $1.16M | $643000.00 | $515000.00 |
| Depreciation & Amortization | $613000.00 | $2.51M | $1.73M | $1.80M |
| EBITDA | -$14.32M | -$5.43M | -$6.07M | -$6.52M |
| EBITDA Ratio | $5.76 | -$1.73 | -$2.45 | -$1.79 |
| Operating Income | -$14.57M | -$7.94M | -$7.83M | -$8.30M |
| Operating Income Ratio | $5.86 | -$2.52 | -$3.16 | -$2.28 |
| Other Income/Expenses (Net) | -$1.40M | -$1.16M | -$613000.00 | -$533000.00 |
| Income Before Tax | -$15.96M | -$9.10M | -$8.44M | -$8.83M |
| Income Before Tax Ratio | $6.43 | -$2.89 | -$3.41 | -$2.43 |
| Income Tax Expense | $14.56M | -$2.51M | -$2.29M | -$2.57M |
| Net Income | -$34.36M | -$6.59M | -$6.15M | -$6.26M |
| Net Income Ratio | $13.83 | -$2.09 | -$2.49 | -$1.72 |
| EPS | -$1.80 | -$0.35 | -$0.33 | -$0.35 |
| Diluted EPS | -$1.80 | -$0.35 | -$0.33 | -$0.35 |
| Weighted Avg Shares Outstanding | $20.46M | $19.08M | $18.89M | $18.05M |
| Weighted Avg Shares Outstanding (Diluted) | $20.46M | $19.08M | $18.89M | $18.05M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan